Skip to content

AUGMENTED ANATOMY: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AUGMENTED ANATOMY

BE 0707.562.243
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€872,850
2024 · -€801,746-€71,104
Equity
€104,775
2024 · -€323,428+€428,203
Cash
€206,330
2024 · €43,591+€162,739
Balance sheet total
€826,662
2024 · €629,753+€196,910

Largest movements

2024 to 2025
Assets
  • Cash +€162,739

    up €162,739 (+373.3%), from €43,591 to €206,330

    mainly Contributions, distributions and other (+€1.3m) and Depreciation (+€208,593)

  • Receivables within one year +€138,785

    up €138,785 (+180.7%), from €76,789 to €215,574

    of which Other amounts receivable: +€131,879

  • Intangible fixed assets -€100,419

    down €100,419 (-21.0%), from €478,515 to €378,095

Equity and liabilities
  • Contributions +€1.3m

    up €1.3m (+62.3%), from €2.1m to €3.4m

  • Profit (loss) carried forward -€872,850

    down €872,850 (-36.2%), from -€2.4m to -€3.3m

  • Debts after one year -€108,659

    down €108,659 (-17.1%), from €633,659 to €525,000

  • Current portion of long-term debt -€79,803

    down €79,803 (-46.1%), from €173,243 to €93,440

  • Tax, wage and social debts -€18,242

    down €18,242 (-33.5%), from €54,466 to €36,224

    of which Remuneration and social security: -€11,845

Income statement
  • Gross operating margin -€128,324

    down €128,324 (-38.1%), from -€337,241 to -€465,565

  • Staff costs -€50,278

    down €50,278 (-23.8%), from €211,572 to €161,294

  • Depreciation +€11,647

    up €11,647 (+5.9%), from €196,946 to €208,593

  • Financial charges -€11,610

    down €11,610 (-30.1%), from €38,588 to €26,979

  • Taxes -€4,702

    down €4,702 (-88.9%), from €5,291 to €589

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€801,746
Gross operating margin -€128,324
Staff costs +€50,278
Depreciation -€11,647
Other operating charges +€2,238
Financial income +€40
Financial charges +€11,610
Taxes +€4,702
Result 2025 -€872,850

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€846,130
Investment -€103,721
Financing +€1.1m
Cash 2024 €43,591
Net result for the year -€872,850
Depreciation +€208,593
Receivables within one year -€138,785
Smaller working-capital items +€1,165
Trade debts -€11,825
Tax, wage and social debts -€18,242
Other debts -€9,460
Accrued charges and deferred income -€4,725
Investment in fixed assets (net) -€103,721
Debts after one year -€108,659
Current portion of long-term debt -€79,803
Contributions, distributions and other +€1.3m
Cash 2025 €206,330
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €629,753 €826,662 +€196,910 +31.3%
Fixed assets 21/28 €489,062 €384,190 -€104,873 -21.4%
Intangible fixed assets 21 €478,515 €378,095 -€100,419 -21.0%
Tangible fixed assets 22/27 €6,358 €1,904 -€4,453 -70.0%
Plant, machinery and equipment 23 €5,015 €1,582 -€3,434 -68.5%
Furniture and vehicles 24 €1,342 €323 -€1,020 -76.0%
Financial fixed assets 28 €4,190 €4,190 = 0.0%
Current assets 29/58 €140,690 €442,473 +€301,782 +214.5%
Amounts receivable within one year 40/41 €76,789 €215,574 +€138,785 +180.7%
Trade receivables 40 €32,701 €39,607 +€6,906 +21.1%
Other amounts receivable 41 €44,088 €175,967 +€131,879 +299.1%
Cash at bank and in hand 54/58 €43,591 €206,330 +€162,739 +373.3%
Deferred charges and accrued income 490/1 €20,310 €20,568 +€257 +1.3%
Total equity and liabilities 10/49 €629,753 €826,662 +€196,910 +31.3%
Equity 10/15 -€323,428 €104,775 +€428,203
Contributions 10/11 €2,089,073 €3,390,126 +€1.3m +62.3%
Profit (loss) carried forward 14 -€2,412,501 -€3,285,352 -€872,850 -36.2%
Amounts payable 17/49 €953,180 €721,887 -€231,293 -24.3%
Amounts payable after more than one year 17 €633,659 €525,000 -€108,659 -17.1%
Financial debts 170/4 €633,659 €525,000 -€108,659 -17.1%
Amounts payable within one year 42/48 €314,796 €196,887 -€117,908 -37.5%
Current portion of amounts payable after more than one year 42 €173,243 €93,440 -€79,803 -46.1%
Trade debts 44 €55,140 €43,314 -€11,825 -21.4%
Suppliers 440/4 €55,140 €43,314 -€11,825 -21.4%
Advances received on contracts in progress 46 - €1,422 +€1,422
Taxes, remuneration and social security 45 €54,466 €36,224 -€18,242 -33.5%
Taxes 450/3 €28,741 €22,344 -€6,397 -22.3%
Remuneration and social security 454/9 €25,725 €13,881 -€11,845 -46.0%
Other amounts payable 47/48 €31,947 €22,486 -€9,460 -29.6%
Accrued charges and deferred income 492/3 €4,725 - -€4,725
Remuneration, social security and pensions 62 €211,572 €161,294 -€50,278 -23.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €196,946 €208,593 +€11,647 +5.9%
Other operating charges 640/8 €12,337 €10,099 -€2,238 -18.1%
Gross operating margin 9900 -€337,241 -€465,565 -€128,324 -38.1%
Operating profit (loss) 9901 -€758,095 -€845,551 -€87,455 -11.5%
Financial income 75/76B €228 €268 +€40 +17.5%
Recurring financial income 75 €228 €268 +€40 +17.5%
Financial charges 65/66B €38,588 €26,979 -€11,610 -30.1%
Recurring financial charges 65 €38,588 €26,979 -€11,610 -30.1%
Profit (loss) for the period before taxes 9903 -€796,456 -€872,261 -€75,806 -9.5%
Income taxes 67/77 €5,291 €589 -€4,702 -88.9%
Profit (loss) for the period 9904 -€801,746 -€872,850 -€71,104 -8.9%
Profit (loss) for the period to be appropriated 9905 -€801,746 -€872,850 -€71,104 -8.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.